Advances in LC-MS Methods for Quantitation of Drugs and Biomarkers in Biological Matrices
6 Feb 2018
James Howard, Scientist, Bioanalytical Sciences, Drug Development Services at LGC, explains how higher sensitivity in peptide bioanalysis is achieved through supercharging reagent, m-NBA (meta nitrobenzyl alcohol). Watch this video to find out how LGC develop LC-MS methods to overcome the challenges that come with the requirement of high sensitivity.
Related Products
Request Quote for All Products
Bioanalysis of peptides service
ResolianOur industry leading bioanalytical solutions have helped our clients develop new peptide therapeutics to improve the quality of life. Combining our experience and cutting-edge technology, we have has developed and validated methods using LC-MS/MS to quantify levels of peptides in plasma at levels as low as 10 pg/mL.
Biopharmaceutical Development Service
ResolianResolian has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 500 scientists across three global labs.
Biomarker testing service
ResolianBiomarker strategy is critical to success. Our personalized biomarker solutions help drive your development to market. The expert biomarker teams support non-clinical and clinical biomarker method development, validation, and sample analysis.
